Health & Medicine
FDA Approves MannKind Corp.’s Inhalable Diabetes Drug Afrezza
The U.S. Food and Drug Administration (FDA) has approved MannKind Corp.'s inhalable insulin Afrezza. The approval allows diabetics to use inhalers instead of needles to control insulin levels.
Latest Research Articles
Lab Grown "Mini Hearts" Help Battle Heart Disease
Excessive Alcohol Consumption to Blame for 1 in 10 Deaths
Poor Sleep Associated with Lower Brain Function in Older Adults
Don't Use Prescription Drugs to Relieve Babies of Teething Pain: FDA Warns
Vegetarian Diet Extends Lifespan, Cuts Greenhouse Emissions: Study
ADHD Medications Linked to Cardiovascular Disease Risk
Treating Your Acne Could Kill You
Daily Intake of Low-Dose Aspirin Linked to Lower Pancreatic Cancer Risk
Vitamin D Supplements Could Help Lower High Blood Pressure: Researchers
Watching Too Much TV can Reduce Lifespan: Study
A Pregnancy Hormone Molecule Can Fight Cancer
Whooping Cough Still Affects a Surprising Number of Vaccinated Children
MOST POPULAR
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Meet The Dire Wolf Trio Remus, Romulus And Khaleesi: How A Texas Lab Revived An Extinct Species
-
Massive New Jersey Wildfire Devastates 8,500 Acres, Threatens Wildlife and Communities Amid Historic Drought
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
